IP Library Granted Patent US 8,420,113
Granted Patent B2
US 8,420,113 · App. 11/350,622 · Granted Apr 16, 2013

Biodegradable medical devices with enhanced mechanical strength and pharmacological functions

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,113
App. No.
11/350,622
Granted
Apr 16, 2013
Kind
B2
Abstract

The present invention is directed to a medical device, specifically a prosthesis which utilizes a novel class of blends between biodegradable polymers and bioceramics for medical device applications allowing one to capitalize on the biodegradable nature of these two distinct materials while enhancing the strength of these devices through the addition of various amounts of bioactive ceramic and glasses to biodegradable polymers. The blend may be fabricated into a medical device such as a stent or a distal protection device, and may incorporate various agents to enhance radioapacity and/or pharmacological function. In addition, the blend may be used as a coating to a medical device.

Claims (3)

1. A medical device comprising an intravascular stent configured as a substantially tubular structure defining a longitudinal axis and having a plurality of longitudinally disposed bands, wherein each band defines a generally continuous wave along a line segment parallel to the longitudinal axis, and a plurality of links that maintain the plurality of bands in a tubular structure, wherein the stent is formed from an inorganic/organic blend including bioactive ceramic particles in an amount ranging from 15 to 25 percent of the blend by volume and biodegradable polymer particles in an amount ranging from 75 to 85 percent of the blend by volume, wherein each of the bioactive ceramic particles is equal to or less than 20 microns in size.

2. The medical device according to claim 1 , wherein the blend further comprises a radiopaque agent.

3. The medical device according to claim 1 , wherein the blend further comprises a pharmaceutical agent.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2025
From: CARDINAL HEALTH SWITZERLAND 515 GMBH; CARDINAL HEALTH 529, LLC; CORDIS CORPORATION; FLEXIBLE STENTING SOLUTIONS, INC
To: CORDIS US CORP
Reel/Frame 072987/0675 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2017
From: CORDIS CORPORATION
To: CARDINAL HEALTH SWITZERLAND 515 GMBH
Reel/Frame 042126/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2006
From: ZHAO, JONATHON Z.
To: CORDIS CORPORATION
Reel/Frame 018034/0934 →